Sai Life Sciences made an impressive stock market debut, listing at a premium of over 18% on December 18, 2024. Shares of the company opened trading at ₹649, significantly above the IPO issue price of ₹549 per share.
Key Sai Life Sciences IPO Details:
- IPO Subscription: Oversubscribed 10.27 times
- Issue Price: ₹549 per share
- Listing Date: December 18, 2024
- Stock Exchanges: BSE and NSE
Strong Listing Performance
Sai Life Sciences shares witnessed solid interest in the special pre-open session, reflecting strong demand driven by the company’s sound fundamentals and robust investor confidence.
Company Overview
Sai Life Sciences is a leading player in the research, development, and manufacturing of small-molecule novel chemical entities (NCEs) for global pharmaceutical and biotech firms. With operations spanning the US, UK, Europe, and Japan, the company’s growing presence and consistent financial performance have played a pivotal role in its successful IPO and subsequent listing.
The listing marks a significant milestone for the company, reaffirming its strong growth trajectory in the pharmaceutical services sector.
